Subcutaneous Drug Delivery: A Review of the State-of-the-Art Modeling and Experimental Techniques

Author:

Sharma Paramveer1,Gajula Kishore1,Dingari Naga Neehar1,Gupta Rakesh1,Gopal Sharath2,Rai Beena1,Iacocca Ronald G.2

Affiliation:

1. Tata Research Development and Design Centre, TCS Research , Pune 411013, India

2. MC 3915, Lilly Corporate Center, Eli Lilly and Company , Indianapolis, IN 46285

Abstract

Abstract Delivery of drug formulations through the subcutaneous route is a widely used modality for the treatment of several diseases, such as diabetes and auto-immune conditions. Subcutaneous injections are typically used to inject low-viscosity drugs in small doses. However, for new biologics, there is a need to deliver drugs of higher viscosity in large volumes. The response of subcutaneous tissue to such high-volume doses and higher viscosity injections is not well understood. Animal models have several drawbacks such as relevance to humans, lack of predictive power beyond the immediate population studied, cost, and ethical considerations. Therefore, a computational framework that can predict the tissue response to subcutaneous injections would be a valuable tool in the design and development of new devices. To model subcutaneous drug delivery accurately, one needs to consider: (a) the deformation and damage mechanics of skin layers due to needle penetration and (b) the coupled fluid flow and deformation of the hypodermis tissue due to drug delivery. The deformation of the skin is described by the anisotropic, hyper-elastic, and viscoelastic constitutive laws. The damage mechanics is modeled by using appropriate damage criteria and damage evolution laws in the modeling framework. The deformation of the subcutaneous space due to fluid flow is described by the poro-hyperelastic theory. The objective of this review is to provide a comprehensive overview of the methodologies used to model each of the above-mentioned aspects of subcutaneous drug delivery. We also present an overview of the experimental techniques used to obtain various model parameters.

Funder

Eli Lilly and Company

Publisher

ASME International

Subject

Physiology (medical),Biomedical Engineering

Reference91 articles.

1. Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy;Arch. Internal Med.,2001

2. Developing the Subcutaneous Drug Delivery Route;Med. Res. Arch.,2017

3. Subcutaneous Drug Delivery: An Evolving Enterprise;Sci. Transl. Med.,2017

4. Variability of the metabolic Effect of Soluble Insulin and the Rapid-Acting Insulin Analog Insulin Aspart;Diabetes Care,1998

5. Effective Method for Drug Injection Into Subcutaneous Tissue;Sci. Rep.,2017

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3